Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. 
 J Am Acad Dermatol. 2004 May;50(5):722-33.

Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Tebbs V, McRae S.Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005 May;152(5):939-47

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng TC. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis. 2010 Jun;85(6):318-24.

Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Williams HC. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol. 2014 Jan;15(1):96-105

Arits AH. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomized controlled trial. Lancet Oncol. 2013.

Micali G, Lacarrubba F, Nasca MR, Ferraro S, Schwartz RA. Topical pharmacotherapy for skin cancer: part II. Clinical applications. J Am Acad Dermatol. 2014 Jun;70(6):979.e1-12

Bargman H, Hochman J. Topical Treatment of Bowen’s Disease with 5-Fluorouracil.  J Cutan Med Surg. 2003 Mar-Apr;7(2):101-5.

Chitwood K, Etzkorn J, Cohen G. Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons. Dermatol Surg. 2013 Sep;39(9):1306-16

Peris K, Micantonio T, Fargnoli MC, Lozzi GP, Chimenti S. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Am Acad Dermatol. 2006 Aug;55(2):324-7.

Rosen T, Harting M, Gibson M. Treatment of Bowen’s Disease with Topical 5% Imiquimod Cream: Retrospective Study. Dermatol Surg. 2007 Apr;33(4):427-31; discussion 431-2.

Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen’s disease. J Am Acad Dermatol. 2001 Mar;44(3):462-70

Patel GK, Goodwin R, Chawla M, Laidler P, Price PE, Finlay AY, Motley RJ. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen’s disease): A randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2006 Jun;54(6):1025-32

Love WE, Bernhard JD, Bordeaux JS. Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma. Arch Dermatol. 2009 Dec;145(12):1431-8

Basal Cell Skin Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Fev

Squamous Cell Skin Cancer, Version 1.2021, NCCM Clinical Practice Guidelines in Oncolofgy, 2021, Fev